ProAssurance Croissance future
Future contrôle des critères 1/6
Le chiffre d'affaires de ProAssurance devrait diminuer de 2.8% par an tandis que ses bénéfices annuels devraient croître de 8.6% par an. Le BPA devrait croître de de 7.2% par an. Le rendement des capitaux propres devrait être 4.9% dans 3 ans.
Informations clés
8.6%
Taux de croissance des bénéfices
7.22%
Taux de croissance du BPA
| Insurance croissance des bénéfices | 2.0% |
| Taux de croissance des recettes | -2.8% |
| Rendement futur des capitaux propres | 4.90% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 26 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
PRA: Margins Will Improve While Revenue Pressures And Fair Value Persist
Analysts have modestly adjusted their price target for ProAssurance, maintaining it at $22.67. Updated forecasts reflect slightly higher discount rates, a softer revenue outlook, improved profit margins, and a marginally lower future price-to-earnings ratio.Future Performance Will Reflect Stable Outlook and Completed Share Repurchase Program
Analysts have slightly adjusted their price target for ProAssurance, maintaining a fair value estimate of $22.67 while taking into account a marginally lower outlook for revenue growth and profit margins. What's in the News ProAssurance reported it repurchased zero shares between April 1, 2025 and June 30, 2025, resulting in no additional spending on buybacks in this period (Key Developments).AI-Ready Web Portal Will Improve Future Customer Experience And Operational Workflows
Analysts have lowered their price target for ProAssurance from $25.00 to $22.67. This change reflects revised expectations around the company’s fair value based on recent financial performance.AI-Ready Web Portal Will Improve Future Customer Experience And Operational Workflows
Upward revisions in ProAssurance's consensus revenue growth forecasts and higher future P/E expectations have contributed to a significant increase in the fair value estimate, with the analyst price target rising from $22.67 to $25.00. What's in the News ProAssurance has completed the repurchase of 12,758,534 shares (22.5%) for $490.42 million under the buyback announced in 2011, with no shares repurchased from April 1, 2025 to June 30, 2025.ProAssurance Pops On Acquisition News, But Think Twice About Opportunity Cost
Summary ProAssurance Corporation (PRA) is being acquired by The Doctors Company, resulting in a 48% stock gain, with an 8% discount remaining on the buyout price. The acquisition, valued at $1.3 billion, is not subject to financing conditions, reducing the risk of deal failure due to funding issues. PRA's financials show modest growth and challenges, with a declining book value and underperforming return on capital employed compared to peers. Despite the high likelihood of deal closure, I recommend holding off on buying PRA now due to potential opportunity costs and waiting for a lower price. Read the full article on Seeking Alpha
AI And Predictive Analytics Initiatives Will Strengthen Future Net Margins
Strategic pricing and predictive analytics improve medical professional liability metrics, potentially enhancing revenue and margins.ProAssurance: Recent Performance Strong, But Valuation Not Compelling
Summary ProAssurance specialises in medical malpractice insurance, facing systemic negative trends and a challenging mono-line business model that suppresses ROE below capital costs. Despite recent stabilization, PRA's valuation on forward earnings is high compared to peers, and growth and momentum are slowing. ProAssurance's net income improvement is driven by increased pricing, re-underwriting initiatives, and higher interest rates, but there's no evidence of pricing above claims trends. SA Quant rates PRA stock a Strong Buy. I share how I see things. Read the full article on Seeking AlphaProAssurance Corporation's (NYSE:PRA) Price Is Out Of Tune With Revenues
It's not a stretch to say that ProAssurance Corporation's ( NYSE:PRA ) price-to-sales (or "P/S") ratio of 0.7x right...Lacklustre Performance Is Driving ProAssurance Corporation's (NYSE:PRA) Low P/S
When close to half the companies operating in the Insurance industry in the United States have price-to-sales ratios...Results: ProAssurance Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
A week ago, ProAssurance Corporation ( NYSE:PRA ) came out with a strong set of first-quarter numbers that could...ProAssurance (NYSE:PRA) Is Due To Pay A Dividend Of $0.05
The board of ProAssurance Corporation ( NYSE:PRA ) has announced that it will pay a dividend on the 13th of April, with...ProAssurance declares $0.05 dividend
ProAssurance (NYSE:PRA) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.94% Payable Oct. 13; for shareholders of record Sept. 29; ex-div Sept. 28. See PRA Dividend Scorecard, Yield Chart, & Dividend Growth.ProAssurance Non-GAAP EPS of $1.19 beats by $1.10
ProAssurance press release (NYSE:PRA): Q2 Non-GAAP EPS of $1.19 (vs. $1.52 Y/Y) beats by $1.10. Gross premiums written were $9.58B (vs. $9.50B Y/Y).ProAssurance's (NYSE:PRA) Dividend Will Be US$0.05
ProAssurance Corporation ( NYSE:PRA ) will pay a dividend of US$0.05 on the 8th of October. This payment means the...ProAssurance (NYSE:PRA) Is Due To Pay A Dividend Of US$0.05
ProAssurance Corporation ( NYSE:PRA ) has announced that it will pay a dividend of US$0.05 per share on the 8th of...Need To Know: Analysts Are Much More Bullish On ProAssurance Corporation (NYSE:PRA) Revenues
Shareholders in ProAssurance Corporation ( NYSE:PRA ) may be thrilled to learn that the analysts have just delivered a...We Wouldn't Be Too Quick To Buy ProAssurance Corporation (NYSE:PRA) Before It Goes Ex-Dividend
It looks like ProAssurance Corporation ( NYSE:PRA ) is about to go ex-dividend in the next four days. You can purchase...Should You Buy ProAssurance Corporation (NYSE:PRA) For Its Dividend?
Is ProAssurance Corporation ( NYSE:PRA ) a good dividend stock? How can we tell? Dividend paying companies with growing...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 1,033 | 91 | N/A | N/A | 1 |
| 12/31/2027 | 1,015 | 65 | N/A | N/A | 3 |
| 12/31/2026 | 1,035 | 60 | N/A | N/A | 3 |
| 3/31/2026 | 1,095 | 65 | -39 | -35 | N/A |
| 12/31/2025 | 1,109 | 51 | -29 | -26 | N/A |
| 9/30/2025 | 1,118 | 34 | -18 | -13 | N/A |
| 6/30/2025 | 1,127 | 49 | -32 | -26 | N/A |
| 3/31/2025 | 1,138 | 42 | -19 | -11 | N/A |
| 12/31/2024 | 1,144 | 53 | -20 | -11 | N/A |
| 9/30/2024 | 1,162 | 43 | -22 | -14 | N/A |
| 6/30/2024 | 1,147 | -23 | -18 | -13 | N/A |
| 3/31/2024 | 1,149 | -28 | -37 | -32 | N/A |
| 12/31/2023 | 1,137 | -39 | -55 | -50 | N/A |
| 9/30/2023 | 1,132 | -31 | -87 | -83 | N/A |
| 6/30/2023 | 1,131 | 9 | -92 | -88 | N/A |
| 3/31/2023 | 1,095 | -3 | -78 | -74 | N/A |
| 12/31/2022 | 1,107 | 0 | -34 | -30 | N/A |
| 9/30/2022 | 1,125 | 18 | 7 | 11 | N/A |
| 6/30/2022 | 1,162 | 39 | 36 | 39 | N/A |
| 3/31/2022 | 1,187 | 133 | 56 | 60 | N/A |
| 12/31/2021 | 1,124 | 144 | 70 | 74 | N/A |
| 9/30/2021 | 1,041 | 126 | 86 | 89 | N/A |
| 6/30/2021 | 958 | -36 | 116 | 121 | N/A |
| 3/31/2021 | 898 | -146 | 127 | 133 | N/A |
| 12/31/2020 | 875 | -176 | 85 | 92 | N/A |
| 9/30/2020 | 895 | -249 | 82 | 93 | N/A |
| 6/30/2020 | 910 | -82 | 61 | 72 | N/A |
| 3/31/2020 | 928 | -53 | 92 | 102 | N/A |
| 12/31/2019 | 1,000 | 1 | N/A | 148 | N/A |
| 9/30/2019 | 930 | 36 | N/A | 160 | N/A |
| 6/30/2019 | 937 | 50 | N/A | 191 | N/A |
| 3/31/2019 | 954 | 67 | N/A | 138 | N/A |
| 12/31/2018 | 886 | 47 | N/A | 177 | N/A |
| 9/30/2018 | 916 | 89 | N/A | 202 | N/A |
| 6/30/2018 | 895 | 87 | N/A | 172 | N/A |
| 3/31/2018 | 844 | 78 | N/A | 177 | N/A |
| 12/31/2017 | 866 | 107 | N/A | 173 | N/A |
| 9/30/2017 | 895 | 145 | N/A | 158 | N/A |
| 6/30/2017 | 891 | 150 | N/A | 150 | N/A |
| 3/31/2017 | 900 | 173 | N/A | 182 | N/A |
| 12/31/2016 | 870 | 151 | N/A | 179 | N/A |
| 9/30/2016 | 818 | 131 | N/A | 135 | N/A |
| 6/30/2016 | 769 | 108 | N/A | 144 | N/A |
| 3/31/2016 | 758 | 98 | N/A | 131 | N/A |
| 12/31/2015 | 772 | 116 | N/A | 111 | N/A |
| 9/30/2015 | 804 | 146 | N/A | 100 | N/A |
| 6/30/2015 | 833 | 171 | N/A | 121 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de PRA ( 8.6% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de PRA ( 8.6% par an) devraient croître plus lentement que le marché US ( 16.8% par an).
Croissance élevée des bénéfices: Les bénéfices de PRA devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Les revenus de PRA devraient diminuer au cours des 3 prochaines années ( -2.8% par an).
Croissance élevée des revenus: Les revenus de PRA devraient diminuer au cours des 3 prochaines années ( -2.8% par an).
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de PRA devrait être faible dans 3 ans ( 4.9 %).
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/26 18:56 |
| Cours de l'action en fin de journée | 2026/05/26 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
ProAssurance Corporation est couverte par 10 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Robert Farnam | Brean Capital Historical (Janney Montgomery) |
| Matthew Carletti | Citizens JMP Securities, LLC |
| Meyer Shields | Keefe, Bruyette, & Woods |